Discovery of molecular glues for modulating MHC presentation of cancer neoantigens

Avatar
Poster
Voice is AI-generated
Connected to paperThis paper is a preprint and has not been certified by peer review

Discovery of molecular glues for modulating MHC presentation of cancer neoantigens

Authors

Shen, W.; Zhang, Z.; He, C.; Guiley, K. Z.; Lashkari, V. D.; Hernandez, J.; Bruno, P. M.; Shokat, K. M.

Abstract

Antigen presentation by MHC class I molecules is essential for cancer immunosurveillance, but many cancer-specific antigens fail to form complexes with Class I MHC and are poorly presented on the cell surface. In this study, we present a chemical strategy to overcome this limitation by identifying peptide MHC glues (PMGs) that promote the formation of peptide-MHC complexes with otherwise unpresentable cancer antigens. Crystal structures of these complexes show that our compounds stabilize antigen-MHC binding by making simultaneous interactions with the MHC protein and the antigen peptides. These findings reveal a new approach for chemically rewiring Class I MHC antigen presentation and accessing rare cancer antigens for therapeutic targeting.

Follow Us on

0 comments

Add comment